返回 Agenda
Session 1 : Regulatory Overview of Cell and Gene Therapy Field
Session Chair(s)
Youngju Choi, PHD
Director General of Biopharmaceutical & Herbal Medicine Evaluation Department
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
In-sook Park, PHD
Director General
Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Caroline Pothet, PHARMD, RPH, RAC
European Medicines Agency, Netherlands
Head of advanced therapies and haemato-oncology
Maria Vassileva, PHD
DIA, United States
Chief Science and Regulatory Officer
Yasuhiro Kishioka, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of Cellular and Tissue-based Products
Jianchao Gao, MD
Changping Laboratory, China
Associate Researcher
So-Young Wang
Ministry of Food & Drug Safety, Korea, Republic of
Director, CGT Products Div, Biopharmaceuticals & Herbal Med Evaluation Dept.
Meehyun Jung
CTX, Inc., Korea, Republic of
Executive Director
MinYoung Kim
CHA University School of Medicine , Korea, Republic of
Professor
Jungtae Park
Korea Biomedicine Industry Association, Korea, Republic of
Vice Chairman